Biocad   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: St Petersburg Russian Federation (2001)

Organization Overview

First Clinical Trial
2011
NCT01701232
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Biocad | CJCS BIOCAD | CJSC Biocad | JCS BIOCAD | JSC BIOCAD | R&D vice-president of JSC BIOCAD